UnitedHealth Group Incorporated $UNH Shares Purchased by Allspring Global Investments Holdings LLC

Key Points

• Allspring Global Investments Holdings increased its UnitedHealth Group stake by 55.5% in the third quarter, adding 71,264 shares to reach 199,606 shares valued at about $72.9 million.
• Analyst sentiment is generally positive: 20 analysts rate UNH a Buy and eight a Hold, giving it a “Moderate Buy” consensus and an average price target of $463.93.
• UnitedHealth beat quarterly earnings and revenue estimates, reporting EPS of $4.69 and revenue of $112.72 billion. It also announced a quarterly dividend of $2.32 per share, equivalent to a 2.3% annualized yield.

Allspring Global Investments Holdings LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 55.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 199,606 shares of the healthcare conglomerate's stock after acquiring an additional 71,264 shares during the quarter. Allspring Global Investments Holdings LLC's holdings in UnitedHealth Group were worth $72,896,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Wellington Altus USA Inc. increased its holdings in UnitedHealth Group by 97.1% during the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate's stock worth $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak bought a new position in shares of UnitedHealth Group during the 2nd quarter worth $29,000. Nvwm LLC increased its stake in shares of UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate's stock valued at $26,000 after buying an additional 33 shares during the period. Aberdeen Wealth Management LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $31,000. Finally, Compass Wealth Management LLC purchased a new stake in UnitedHealth Group in the third quarter worth about $29,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $526.00 to $487.00 and set an "overweight" rating on the stock in a report on Tuesday, October 27th. Wall Street Zen raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Erste Group Bank downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Thursday, August 27th. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $516.00 to $524.00 and gave the company an "overweight" rating in a report on Friday, October 16th. Finally, Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $440.00 to $495.00 and gave the stock an "overweight" rating in a research note on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average price target of $463.93.

UnitedHealth Group Stock Performance

UNH stock opened at $396.97 on Tuesday. The firm has a market cap of $355.70 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 1.48 and a beta of 0.51. The firm has a 50-day simple moving average of $390.68 and a two-hundred day simple moving average of $364.28. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.14 by $0.55. The firm had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company's quarterly revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group's payout ratio is 53.00%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company's stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.19% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.